Terazosin Hydrochloride Capsule
Product Images NDC 71610-595

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Terazosin Hydrochloride (NDC 71610-595). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle Label 10 mg (71610 0594 60)

Label for Terazosin Hydrochloride 10 mg capsules, containing 90 capsules. The label indicates storage instructions between 20-25 degrees Celsius and mentions the product is manufactured by Aprar Pharma LLC, Chino, CA, and repackaged by Aphena Pharma Solutions, Cookeville, TN. The label includes an NDC number and states the product is RX only.*

FDA Label Image

Bottle Label 5 mg (71610 0595 60)

Label for Terazosin Hydrochloride 5 mg capsules, containing 90 capsules per container. The label shows the NDC number 71610-0595-60 and states storage instructions between 20-25 degrees Celsius. Manufactured by Aphena Pharma LLC, Chino, CA, and repackaged by Aphena Pharma, Cookeville, TN.*

FDA Label Image

Aphena Pharma Solutions (TN)

FDA Label Image

Terazosinhydrochloridechemicalstructure (Chemicalstructure)

Chemical structure of Terazosin Hydrochloride, depicting its molecular framework including aromatic rings, nitrogen atoms, methoxy groups, and the hydrochloride component.*

FDA Label Image

Figure1 (Figure1)

Two line graphs comparing placebo and Terazosin treatment effects over three months. The left graph shows mean change in total symptom score from baseline, with Terazosin showing a greater decrease. The right graph shows mean increase in peak flow rate from baseline, with Terazosin showing a greater increase. Sample sizes for placebo and Terazosin groups range from 52 to 55 participants.*

FDA Label Image

Figure2 (Figure2)

A line graph depicting mean change from baseline over 30 months. The x-axis shows time in months from 0 to 30, and the y-axis shows mean change values from 0 to -7. Data points are marked with open circles and include several asterisks indicating notable values. The graph illustrates a trend of decreasing mean change from baseline over time.*

FDA Label Image

Figure3 (Figure3)

A line graph showing mean change from baseline (in mL/sec) over a 30-month period. The x-axis represents time in months from 0 to 30, and the y-axis represents mean change from baseline ranging from 0 to 4.5 mL/sec. Data points include error bars, with several marked by asterisks indicating statistical significance.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.